Drug Shortage Report for NRA-OLMESARTAN HCTZ
Report ID | 248784 |
Drug Identification Number | 02508281 |
Brand name | NRA-OLMESARTAN HCTZ |
Common or Proper name | NRA-Olmesartan HCTZ |
Company Name | NORA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | OLMESARTAN MEDOXOMIL HYDROCHLOROTHIAZIDE |
Strength(s) | 40MG 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | Blister 30, Bottle 90 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-12-16 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 LIONEL-BOULET BLVD. VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-04-08 | French | Compare |
v3 | 2025-04-08 | English | Compare |
v2 | 2025-01-28 | French | Compare |
v1 | 2025-01-28 | English | Compare |
Showing 1 to 4 of 4